Home
About this system
Release history
Contact us

SIXFOLD BIOSCIENCE LTD.

W12 0BZ (London)

Go back

Reset results to starting set

The following are buttons which change the sort order, pressing the active button will toggle the sort order

Start Date End Date Funded Value Relevance

descending (press to sort ascending)

CSV

Download all search results to a CSV file?

Large result sets may take several minutes to download.
The first row is header row.
Generation of CSV export files is restricted, and may be rejected during busy periods. If this happens then please wait and try again after a brief interval.

25 50 100

Refine

£36,890

Mar 20 - Feb 21

Effective analysis and manipulation of the protein corona - increasing the efficacy of Sixfold’s delivery system for Cell and Gene therapeutics

Innovate UK award to SIXFOLD BIOSCIENCE LTD. and Anna Perdrix Rosell

£23,132

Oct 19 - Mar 21

Developing a method for in vivo quantification and analysis of Sixfold’s Programmable Oligonucleotide Delivery System (PODS) for siRNA cancer therapy

Innovate UK award to SIXFOLD BIOSCIENCE LTD. and Anna Perdrix Rosell

£96,789

Dec 21 - Jan 22

Resilience-TARGET: RNA nanotechnology delivery platform for RNA therapies

Innovate UK award to SIXFOLD BIOSCIENCE LTD. and Anna Perdrix Rosell

£125,763

Feb 21 - Jan 23

High-throughput approach for improving RNA nanoparticles as drug delivery agents

Innovate UK award to IMPERIAL COLLEGE LONDON and Elena Sanna Martinez

£126,331

Dec 20 - Nov 22

University of Newcastle Upon Tyne and Sixfold Bioscience Limited

Innovate UK award to UNIVERSITY OF NEWCASTLE UPON TYNE

£8,995

Aug 23 - Jan 24

Investigation of Mergo? mechanism of action by quantitative serum protein profiling.

Innovate UK award to SIXFOLD BIOSCIENCE LTD. and Anna Perdrix Rosell

£22,402

Oct 19 - Dec 20

Effective measurement and analysis for optimisation of Sixfold’s functionally enhanced Programmable Oligonucleotide Delivery System (PODS) for delivery of Cell and Gene therapeutics

Innovate UK award to SIXFOLD BIOSCIENCE LTD. and Anna Perdrix Rosell

£385,501

Jul 23 - Jun 25

ENHANCE: Scaling up development of novel Mergo® formulations via optimised synthesis and high-throughput strategies

Innovate UK award to SIXFOLD BIOSCIENCE LTD. and Anna Perdrix Rosell

£249,760

Oct 20 - Sep 21

RNA nanotechnology for rapid and sustainable preclinical iteration of gene therapeutics

Innovate UK award to SIXFOLD BIOSCIENCE LTD. and Anna Perdrix Rosell

£152,129

Oct 20 - Dec 22

PROPEL

Innovate UK award to SIXFOLD BIOSCIENCE LTD. and Anna Perdrix Rosell

£671,322

Apr 22 - Mar 24

SUMMIT: SiRNAs Utilising Mergo? delivery for post-Myocardial Infarction Treatment

Innovate UK award to SIXFOLD BIOSCIENCE LTD. and Anna Perdrix Rosell

£382,398

Nov 20 - Apr 22

TARGET: RNA nanotechnology delivery platform for gene therapies, towards commercialization in cancer

Innovate UK award to SIXFOLD BIOSCIENCE LTD. and Anna Perdrix Rosell

£57,607

Jun 20 - Nov 20

Covid-19 continuity: Effective measurement and analysis for optimisation of Sixfold’s functionally enhanced Programmable Oligonucleotide Delivery System (PODS) for delivery of Cell and Gene therapeutics

Innovate UK award to SIXFOLD BIOSCIENCE LTD. and Anna Perdrix Rosell

£78,962

Jan 21 - Mar 21

RAPOD: Rapid Assembly of Programmable Oligonucleotide Delivery systems for increased gene therapeutic load

Innovate UK award to SIXFOLD BIOSCIENCE LTD. and Anna Perdrix Rosell

£349,883

Nov 23 - Oct 25

INDUCE: Development of siRNA-Mergo® therapeutics for lung indications.

Innovate UK award to SIXFOLD BIOSCIENCE LTD. and Anna Perdrix Rosell

Help

Refine by :

Data

The Data on this website provides information about publications, people, organisations and outcomes relating to research projects

APIs

A set of REST API's enable programmatic access to the data. Refer to the application programming interfaces GtR and GtR-2

Contact

UKRI Gateway
Polaris House
Swindon
SN2 1ET
gateway@ukri.org

Privacy | Terms of Use | OGL Data last updated: 18 Apr 2024